BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer. (2017)

First Author: Shimelis H

Attributed to: King's Health Partners Confidence in Concept funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-16-2568

PubMed Identifier: 28283652

Publication URI: http://europepmc.org/abstract/MED/28283652

Type: Journal Article/Review

Volume: 77

Parent Publication: Cancer research

Issue: 11

ISSN: 0008-5472